SLU-PP-332 5mg | ERRα Agonist Exercise Mimetic |

⚠️ ATTENTION: STRICTLY FOR LABORATORY RESEARCH USE ONLY. This product is NOT FOR HUMAN CONSUMPTION, medical use, veterinary use, or diagnostic use. By purchasing, you agree to handle this compound in compliance with all local and federal regulations. No medical or clinical advice is provided; this description serves exclusively as a biochemical and mechanistic overview for advanced research purposes.

SLU-PP-332: The Apex of Transcriptomic Reprogramming & Exercise Mimetics

SLU-PP-332 represents a monumental paradigm shift in the laboratory investigation of metabolic dysfunction, endurance capacity, and mitochondrial bio-energetics. Unlike traditional peptides that target cell-surface receptors (such as GLP-1 or GIP) to modulate systemic hormones, SLU-PP-332 is a highly specialized small-molecule compound classified as a selective Estrogen-Related Receptor-alpha (ERRα) agonist.

In the specialized landscape of molecular biology, SLU-PP-332 is widely recognized by researchers as a true “exercise mimetic.” It is explicitly engineered to bypass the mechanical triggers of physical exertion, directly activating the nuclear receptors responsible for the genetic adaptations that are usually only caused by intense, sustained endurance training. In preclinical animal models, SLU-PP-332 has demonstrated the unprecedented ability to fundamentally reprogram the metabolic profile of skeletal muscle, shifting tissue phenotypes toward high-efficiency oxidative metabolism and increasing baseline endurance capacity by up to 70% without prior physical conditioning.

The Biochemistry of Nuclear Receptor Activation: The ERRα & PGC-1α Axis

To fully grasp the profound research value of the SLU-PP-332 5mg yield, investigators must examine its precise intracellular mechanism of action. This compound does not manipulate appetite hormones, nor does it slow gastric emptying. Instead, it operates at the nuclear level to edit how a cell expresses its metabolic genes.

1. Direct ERRα Agonism

Estrogen-Related Receptors (specifically the alpha isoform, ERRα) are orphan nuclear receptors that are highly expressed in energy-demanding tissues, including skeletal muscle, cardiac tissue, and the liver. Under normal physiological conditions, these receptors are activated by extreme cellular energy depletion. SLU-PP-332 directly binds to and agonizes ERRα, initiating the transcription of highly specific genes responsible for lipid transport, fatty acid oxidation, and the optimization of the electron transport chain.

2. PGC-1α Co-Activation Synergy

ERRα works in strict physiological concert with PGC-1α (Peroxisome proliferator-activated receptor gamma coactivator 1-alpha), which is widely considered the master biological regulator of mitochondrial biogenesis. By artificially agonizing ERRα, SLU-PP-332 simulates the exact PGC-1α signaling cascade. This biochemical interaction essentially “tricks” the cell into behaving as if the organism is undergoing sustained, rigorous aerobic exertion, triggering a cascade of survival and efficiency adaptations.

3. Skeletal Muscle Fiber Reprogramming

Through these advanced nuclear pathways, SLU-PP-332 forces a structural and metabolic shift within muscle tissue. It converts fast-twitch, glycolytic muscle fibers (which rely on glucose and fatigue rapidly) into a more slow-twitch, oxidative phenotype (which relies on stored lipids and fiercely resists fatigue). This shift mimics the precise cellular transcriptomic signature observed in elite endurance athletes.

Primary Domains of Laboratory Investigation

Detailed Breakdown of Research Applications

I. The “Exercise Mimetic” Endurance Phenomenon

The most heavily researched application of SLU-PP-332 is its profound impact on endurance and stamina without the prerequisite of physical conditioning. In landmark preclinical studies, subjects administered SLU-PP-332 ran significantly further and for much longer durations on treadmills compared to control groups. Researchers utilize this 5mg compound to study the molecular pathways of stamina, focusing on how isolated chemical signaling can upregulate the oxidative capacity of skeletal muscle independently of central nervous system fatigue or cardiovascular strain.

II. Accelerated Fat Oxidation & Non-Catabolic Body Composition

While popular GLP-1 drugs force weight loss through severe caloric restriction (appetite suppression), SLU-PP-332 approaches obesity and metabolic syndrome modeling entirely from the energy expenditure side. By upregulating the specific genes responsible for fatty acid uptake into the mitochondria, it forces the organism to utilize stored lipids as its primary energy currency. Researchers use SLU-PP-332 to investigate non-catabolic fat loss—effectively reducing visceral and subcutaneous adipose tissue while preserving, or even actively enhancing, lean muscle function and density.

III. Reversing Metabolic Inflexibility

Metabolic inflexibility—defined as the inability of a cell to efficiently switch between burning carbohydrates and burning fat depending on availability—is a primary cellular hallmark of type 2 diabetes, obesity, and advanced aging. SLU-PP-332 serves as a premier research subject for studying the restoration of this biological flexibility. By optimizing mitochondrial gene expression, it allows researchers to study the rapid clearance of intracellular lipids and the restoration of systemic insulin sensitivity at the deepest nuclear level.

Comparative Advantage: SLU-PP-332 vs. MOTS-c vs. GLP-1 Agonists

In advanced biochemical research, scientists must carefully distinguish between Input Control, Metabolic Sensing, and Nuclear Reprogramming:

• GLP-1 Agonists (e.g., Semaglutide): Modulate Input. They change how much an organism eats and artificially slow digestion. They do not intrinsically improve muscle function or mitochondrial density.

• Mitochondrial Peptides (e.g., MOTS-c): Modulate Sensing. They activate AMPK in response to metabolic stress, acting as a mitochondrial-to-nuclear messenger to improve systemic insulin sensitivity.

• ERRα Agonists (SLU-PP-332): Modulate Programming. This compound bypasses the biological stress sensors and directly edits the nuclear transcription. It forcefully reprograms the muscle tissue to adopt an endurance-trained, fat-burning phenotype. It is the absolute closest mechanistic relative to actual physical training currently available for laboratory study.

Laboratory Specifications & Compound Profile

This ultra-premium formulation is synthesized exclusively for rigorous laboratory environments demanding absolute molecular stability, verified receptor affinity, and uncompromising purity.

• Product Classification: Small Molecule / Selective ERRα Agonist.

• Chemical Name / Identifier: SLU-PP-332

• Molecular Weight: 447.43 g/mol

• Dosage / Yield: High-Capacity 5mg (5,000mcg) Lyophilized Powder.

• Vial Capacity: Standard 10ML clinical research format.

• Purity Standard: 99%+ (Independent Third-Party Lab Verified via High-Performance Liquid Chromatography and Mass Spectrometry).

• Storage Requirements: Store lyophilized powder at -20°C for maximum long-term stability. Avoid repeated freeze-thaw cycles. Once reconstituted with bacteriostatic water, refrigerate immediately at 2°C to 8°C and utilize within standard research protocols.